Categories : Endocrine & Metabolic
Product Packaging : 10 / 30 tablets
Product Composition : 10 mg
Send MessageDapagliflozin Tablets are an advanced oral antidiabetic therapy belonging to the sodium-glucose co-transporter 2 (SGLT2) inhibitor class, specifically developed for effective glycemic control in type 2 diabetes mellitus. This innovative mechanism reduces renal glucose reabsorption, leading to increased urinary glucose excretion and improved blood sugar regulation without directly stimulating insulin secretion.
Beyond glucose control, Dapagliflozin is widely utilized for its additional benefits in supporting cardiovascular health, reducing hospitalization due to heart failure, and offering renal protection in patients with chronic conditions. Its expanding clinical applications make it a preferred choice in modern diabetes and cardiometabolic management strategies.
Genliva Wellness LLP, Himatnagar, India, is a trusted dapagliflozin tablet manufacturer India and SGLT2 inhibitor tablets exporter India, delivering high-quality, WHO-GMP compliant formulations to hospitals, endocrinology clinics, pharmacies, and international pharmaceutical markets.
Dapagliflozin Tablets are SGLT2 inhibitor medications used to help control blood glucose levels in patients with type 2 diabetes mellitus. They work by promoting the removal of excess glucose through urine and support overall metabolic health.
These tablets are commonly used for the treatment of type 2 diabetes mellitus along with diet and exercise. They help improve glycemic control and support overall diabetes management.
Dapagliflozin Tablets provide effective blood sugar control with additional metabolic and cardiovascular support, improving patient convenience and treatment outcomes.
